Showing results (1031-1040 of 5,682) with videos related to

Sort By:
Pageof 569
Infection|August 12, 2023
Trends in mortality after a sepsis hospitalization: a nationwide prospective registry study from 2008 to 2021Nina Vibeche Skei, Tom Ivar Lund Nilsen, Randi Marie Mohus, et al.
Infection|October 9, 2023
No evidence of an association of multiple sclerosis (MS) with Borna disease virus 1 (BoDV-1) infections in patients within an endemic region: a retrospective pilot studyMarkus Bauswein, Gertrud Knoll, Barbara Schmidt, et al.
Infection|September 30, 2023
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature reviewMyriam Drysdale, Daniel C Gibbons, Moushmi Singh, et al.
Infection|September 27, 2023
Cytokine storm and severe hepatitis in pregnancy due to herpes simplex virus 2Alessandra Mularoni, Andrea Cona, Lùcia Ribeiro Dias, et al.
Infection|July 18, 2023
Strongyloides stercoralis infection: an underlying cause of invasive bacterial infections of enteric origin. Results from a prospective cross-sectional study of a northern Italian tertiary hospitalGiulia Gardini, Guenter Froeschl, Francesca Gurrieri, et al.
Infection|July 11, 2023
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)Fridolin Steinbeis, Charlotte Thibeault, Sarah Steinbrecher, et al.
Infection|June 29, 2023
Infective endocarditis involving MitraClip© devices: a systematic literature reviewLorenzo Bertolino, Mohammad Said Ramadan, Rosa Zampino, et al.
Infection|December 4, 2018
Correction to: A review on anti-adhesion therapies of bacterial diseasesArezoo Asadi, Shabnam Razavi, Malihe Talebi, et al.
Infection|February 7, 2019
In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluidValentin Al Jalali, Robert Sauermann, Sabine Eberl, et al.
Infection|January 29, 2019
HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?Linda Drößler, Clara Lehmann, Karin Töpelt, et al.
Pageof 569